CSPI Targets OTC Male Enhancement Products With Enzyte FTC Letter
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission should immediately enjoin national television ads for Berkeley Premium Nutraceuticals' herbal supplement Enzyte, according to the Center for Science in the Public Interest